Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer
NCT ID: NCT03818620
Last Updated: 2025-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
3000 participants
OBSERVATIONAL
2017-06-07
2025-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Utility of Digital Dermoscopy in the Skin Cancer Clinic
NCT03497455
DERM US and EU Validation Study
NCT05126173
Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management
NCT04789421
Imaging Methods for the Diagnosis of Non-melanoma Skin Cancer and Its Precursors
NCT05842421
Reflectance Confocal Microscopy in Basal Cell Carcinoma
NCT02623101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Barco digital dermatoscope device images
Images of skin lesion taken with the Barco dermatoscope by site team member
Reference standard dermatoscope device images
Images of skin lesion taken with a standard dermatoscope device (as part of standard care)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient gives informed consent
* Men or women of any ethnic group aged ≥ 18 years
Exclusion Criteria
* Patients not willing or able to read, understand and sign the study-specific informed consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Barco NV
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marjan Garmyn, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
UZ / KU Leuven
Lieve Brochez, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
UZ Gent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Gent
Ghent, , Belgium
UZ / KU Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B322201732457
Identifier Type: OTHER
Identifier Source: secondary_id
80M0675
Identifier Type: OTHER
Identifier Source: secondary_id
CI-PROT-0010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.